Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With Myelofibrosis
Clinical trial NCT04454658 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04454658
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-11
- Primary completion
- 2027-01-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.